FDA product code DQE: Catheter, Oximeter, Fiber-Optic
DQE is the FDA product code for catheter, oximeter, fiber-optic. It is a Class II device, regulated under 21 CFR 870.1230 and reviewed by the Cardiovascular panel. FDA has cleared 19 510(k) submissions under DQE, from 8 different applicants. The average 510(k) review took 108 days (median 71). FDA has posted 14 recalls for DQE devices.
Classification
| Field | Value |
|---|---|
| Device name | Catheter, Oximeter, Fiber-Optic |
| Device class | Class II |
| Regulation | 21 CFR 870.1230 |
| Review panel | CV — Cardiovascular |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for DQE
| Year | Clearances | Avg. review days |
|---|---|---|
| 2018 | 1 | 194 |
Compare with all 510(k) review times · Search every DQE clearance
Top DQE applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Hospira, Inc. | 5 | 2009-09-18 |
| Edwards Lifesciences, LLC | 4 | 2016-06-16 |
| Baxter Healthcare Corp | 3 | 1993-02-22 |
| Oximetrix, Inc. | 3 | 1982-03-25 |
| Edwards Lifescience, LLC | 1 | 2018-02-20 |
3 more applicants have DQE clearances. See the full list in Caduvo.
Most recent DQE clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K172423 | Edwards Lifescience, LLC | PediaSat Oximetry Catheter, PreSep Oligon Oximetry Catheter, Edwards Oximetry Central Venous Catheter (previously PreSep Oximetry Catheter) | 2018-02-20 | 194 |
| K160645 | Edwards Lifesciences, LLC | PreSep Oligon Oximetry Catheter | 2016-06-16 | 101 |
| K140129 | Icu Medical, Inc. | PICCOX PERIPHERALLY INSERTED PRESSURE INJECTABLE, CENTRAL VENOUS OXIMETRY CATHETER | 2014-07-02 | 167 |
| K110167 | Edwards Lifesciences, LLC | PRESEP OLIGON OXIMETRY CATHETERS (16 CM, W/HEPARIN), (20CM, W/HEPARIN) | 2011-02-18 | 29 |
| K091268 | Hospira, Inc. | HOSPIRA LATEX-FREE CRITICAL CARE AND ADVANCED SENSOR CATHETERS | 2009-09-18 | 141 |
Recalls for DQE devices
14 product recalls in 3 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2021-07-09.
| Year | Recalls |
|---|---|
| 2020 | 8 |
| 2021 | 6 |
Frequently asked questions
What is FDA product code DQE?
DQE is the FDA product code for catheter, oximeter, fiber-optic. It is a Class II device, regulated under 21 CFR 870.1230 and reviewed by the Cardiovascular panel.
What device class is DQE?
Class II, regulation 21 CFR 870.1230. Typical premarket route: 510(k).
How long does a 510(k) take for product code DQE?
Across 19 cleared submissions the average was 108 days from receipt to decision (median 71).
Which companies have the most DQE clearances?
Hospira, Inc. (5); Edwards Lifesciences, LLC (4); Baxter Healthcare Corp (3); Oximetrix, Inc. (3); Edwards Lifescience, LLC (1).
Have DQE devices been recalled?
Yes: 14 product recalls across 3 recall events; the most recent began 2021-07-09.
Next steps
- Run an FDA pathway report with predicate devices for product code DQE
- Run a recall and safety report across every DQE manufacturer
- Watch product code DQE for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times